These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8536501)

  • 1. Evaluation of recombinant human growth hormone for wound management.
    Rasmussen LH
    Dan Med Bull; 1995 Sep; 42(4):358-70. PubMed ID: 8536501
    [No Abstract]   [Full Text] [Related]  

  • 2. Technology evaluation: rh lactoferrin, Agennix.
    Andersen JH
    Curr Opin Mol Ther; 2004 Jun; 6(3):344-9. PubMed ID: 15264438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local administration of nucleosides in dermatology].
    Giacometti F
    Minerva Med; 1970 Sep; 61(78):4279-88. PubMed ID: 4930955
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of somatotropin on wound healing].
    Zieliński S; Zajaczek J; Warmbier W; Stankiewicz S
    Pol Przegl Chir; 1974 Jul; 46(7):1011-5. PubMed ID: 4845747
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of exogenous growth hormone and insulin-like growth factor I in malnutrition and acute metabolic stress: a hypothesis.
    Chwals WJ; Bistrian BR
    Crit Care Med; 1991 Oct; 19(10):1317-22. PubMed ID: 1914490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical application of growth factors and cytokines in wound healing].
    Vogt PM; Drücke D; Mühlberger T; Homann HH; Steinau HU
    Zentralbl Chir; 2000; 125 Suppl 1():65-8. PubMed ID: 10929650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant bovine basic fibroblast growth factor accelerates wound healing in patients with burns, donor sites and chronic dermal ulcers.
    Fu X; Shen Z; Chen Y; Xie J; Guo Z; Zhang M; Sheng Z
    Chin Med J (Engl); 2000 Apr; 113(4):367-71. PubMed ID: 11775238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Naturopathy consultation. Wound management].
    Kraft K
    MMW Fortschr Med; 2012 Nov; 154(21):24-5. PubMed ID: 23270051
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor.
    Tomlinson B
    Curr Opin Investig Drugs; 2006 Oct; 7(10):936-45. PubMed ID: 17086939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of recombinant human epidermal growth factor on chronic ulcer wound].
    Zhu JX; Zhang YM
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):42-3. PubMed ID: 11826651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and treatment of pain in patients with chronic wounds.
    Freedman G; Cean C; Duron V; Tarnovskaya A; Brem H
    Surg Technol Int; 2003; 11():168-79. PubMed ID: 12931299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers.
    Hardin DS; Kemp SF; Allen DB
    Clin Pediatr (Phila); 2007 May; 46(4):279-86. PubMed ID: 17475983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human granulocyte-macrophage colony-stimulating factor as treatment for chronic leg ulcers.
    Borbolla-Escoboza JR; María-Aceves R; López-Hernández MA; Collados-Larumbe MT
    Rev Invest Clin; 1997; 49(6):449-51. PubMed ID: 9528304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic management of problem wounds. Moist wound management is the nonplusultra].
    Soós SN
    MMW Fortschr Med; 2003 Sep; 145(35-36):41-3. PubMed ID: 14584209
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of growth factors for treatment of chronic wounds. Results of controlled studies].
    Senet P; Meaume S
    Ann Dermatol Venereol; 2000 Feb; 127(2):232-6. PubMed ID: 10739992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effect of a growth hormone produced by a Polish manufacturer].
    MANICKI J
    Pol Tyg Lek (Wars); 1958 Jun; 13(26):992-4. PubMed ID: 13601220
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anabolic effects of recombinant human growth hormones following injuries].
    He G; Jiang Z
    Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):312-4. PubMed ID: 7656165
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis.
    Mandracchia VJ; Sanders SM; Frerichs JA
    Clin Podiatr Med Surg; 2001 Jan; 18(1):189-209, viii. PubMed ID: 11344978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic reviews of wound care management: (2). Dressings and topical agents used in the healing of chronic wounds.
    Bradley M; Cullum N; Nelson EA; Petticrew M; Sheldon T; Torgerson D
    Health Technol Assess; 1999; 3(17 Pt 2):1-35. PubMed ID: 10683589
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recombinant human growth hormone (rhGH) administration in a patient with chronic renal insufficiency: renal and metabolic effects].
    Fouque D; Bernard S; Hadj-Aïssa A; Laville M; Zech P; Riou JP
    Nephrologie; 1996; 17(3):171-4. PubMed ID: 9064566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.